Rare variants associated with interval breast cancers

Rare variants associated with interval breast cancers

(HealthDay)—Though common breast cancer variants indicate increased breast cancer risk, certain rare variants are associated with an increased risk for interval breast cancers and death, according to a study published in the Nov. 1 issue of Cancer Research.

Jingmei Li, Ph.D., from the Genome Institute of Singapore, and colleagues assessed whether the genetic risk stratification of breast by rare and common variants in established loci can discriminate tumors with different biology, patient survival, and mode of detection among 5,099 patients with breast cancer diagnosed in Sweden between 2001 and 2008. The genetic risk load was evaluated through protein-truncating variant (PTV) carriership in 31 cancer predisposition genes or polygenic risk score (PRS) using 162 single-nucleotide polymorphisms.

The researchers found that PTV carriers (597 patients) were younger and were associated with more aggressive tumor phenotypes (estrogen receptor-negative, large size, high grade, high proliferation, luminal B, and basal-like subtype) and worse outcome (hazard ratio [HR], 1.65) versus noncarriers. PTV carriership remained associated with high grade and worse survival (HR, 1.76) even after 92 BRCA1/2 carriers were excluded. Higher PRS was associated with less aggressive tumor characteristics (estrogen receptor-positive, progesterone receptor-positive, small size, low grade, low proliferation, and luminal A subtype) in BRCA1/2 noncarriers. In women with low mammographic density, non-BRCA1/2 PTV carriers more often had interval than screen-detected disease (odds ratio, 1.89), but higher PRS was associated with a lower risk for interval-detected versus screen-detected cancer (odds ratio, 0.77).

"These findings offer the potential to improve screening practices for by providing a deeper understanding of how variants affect disease progression and mode of detection," the authors write.

One author disclosed financial ties to AstraZeneca, which partially sponsored the study.

Explore further

Women carrying rare breast cancer variants more likely to develop interval breast cancers

More information: Abstract/Full Text
Journal information: Cancer Research

Copyright © 2018 HealthDay. All rights reserved.

Citation: Rare variants associated with interval breast cancers (2018, December 4) retrieved 9 December 2019 from https://medicalxpress.com/news/2018-12-rare-variants-interval-breast-cancers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments